Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | PF-04136309 |
| Synonyms | |
| Therapy Description |
PF-04136309 is a CCR2 antagonist that inhibits CCR2 signaling, resulting in inhibition of tumor progression (PMID: 27055731, PMID: 31297636). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| PF-04136309 | PF-04136309 is a CCR2 antagonist that inhibits CCR2 signaling, resulting in inhibition of tumor progression (PMID: 27055731, PMID: 31297636). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|